FDA advisers support Acthar as treatment for infantile spasms

05/7/2010 | Reuters

An FDA panel endorsed the approval of Questcor Pharmaceuticals' injectable gel Acthar for infantile spasms. The drug is already approved for other indications, including multiple sclerosis.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN